Regulation of γ-glutamylcysteine synthetase subunit gene expression:: Insights into transcriptional control of antioxidant defenses

被引:167
作者
Wild, AC [1 ]
Mulcahy, RT [1 ]
机构
[1] Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53792 USA
关键词
glutathione; oxidative stress; gene regulation; glutamate-cysteine ligase;
D O I
10.1080/10715760000300291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
gamma-Glutamylcysteine synthetase (GCS; also referred to as glutamate-cysteine ligase, GLCL) catalyzes the rate-limiting reaction in glutathione (GSH) biosynthesis. The GCS holoenzyme is composed of a catalytic and regulatory subunit, each encoded by a unique gene. In addition to some conditions which specifically upregulate the catalytic subunit gene, expression of both genes is increased in response to many Phase II enzyme inducers including oxidants, heavy metals, phenolic antioxidants and GSH-conjugating agents. Electrophile Response Elements (EpREs), located in 5'-flanking sequences of both the GCS(h) and GCS(I) subunit genes, are hypothesized to at least partially mediate gene induction following xenobiotic exposure. Recent experiments indicate that the bZip transcription factor Nrf2 participates in EpRE-mediated GCS subunit gene activation in combination with other bZip proteins. An AP-1-like binding sequence and an NF-kappa B site have also been implicated in regulation of the catalytic subunit gene following exposure to certain pro-oxidants. Potential signaling mechanisms mediating GCS gene induction by the diverse families of Phase II enzyme inducers include thiol modification of critical regulatory sensor species. This review summarizes recent progress in defining the molecular mechanisms operative in transcriptional control of the genes encoding the two GCS subunits, identifying areas of agreement and controversy. The mechanisms involved in GCS regulation might also be relevant to the transcriptional control of other components of the antioxidant defense battery.
引用
收藏
页码:281 / 301
页数:21
相关论文
共 149 条
[1]  
AliOsman F, 1996, MOL PHARMACOL, V49, P1012
[2]   Transforming growth factor-beta(1) is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: Transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase [J].
Arsalane, K ;
Dubois, CM ;
Muanza, T ;
Begin, R ;
Boudreau, F ;
Asselin, C ;
Cantin, AM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (05) :599-607
[3]  
BAILEY HH, 1992, CANCER RES, V52, P5115
[4]   Mechanisms involved in the regulation of key enzymes of cysteine metabolism in rat liver in vivo [J].
Bella, DL ;
Hirschberger, LL ;
Hosokawa, Y ;
Stipanuk, MH .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (02) :E326-E335
[5]  
BERGELSON S, 1994, ONCOGENE, V9, P565
[6]   MODULATION OF GAMMA-GLUTAMYLCYSTEINE SYNTHETASE LARGE SUBUNIT MESSENGER-RNA EXPRESSION BY BUTYLATED HYDROXYANISOLE [J].
BORROZ, KI ;
BUETLER, TM ;
EATON, DL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 126 (01) :150-155
[7]   Identification of glutathione S-transferase isozymes and γ-glutamylcysteine synthetase as negative acute-phase proteins in rat liver [J].
Buetler, TM .
HEPATOLOGY, 1998, 28 (06) :1551-1560
[8]   INDUCTION OF PHASE-I AND PHASE-II DRUG-METABOLIZING ENZYME MESSENGER-RNA, PROTEIN, AND ACTIVITY BY BHA, ETHOXYQUIN, AND OLTIPRAZ [J].
BUETLER, TM ;
GALLAGHER, EP ;
WANG, CH ;
STAHL, DL ;
HAYES, JD ;
EATON, DL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 135 (01) :45-57
[9]   Differential regulation of gamma-glutamylcysteine synthetase heavy and light subunit gene expression [J].
Cai, JX ;
Huang, ZZ ;
Lu, SC .
BIOCHEMICAL JOURNAL, 1997, 326 :167-172
[10]  
CAI JX, 1995, MOL PHARMACOL, V48, P212